Researchers have integrated engineered microbes with optoelectronic devices and smartphone interfaces to create the first fully controllable ingestible therapeutic platform. This system enables real-time monitoring and modulation of microbial activity within the mammalian gut, demonstrated in animal models. Published findings highlight powerful implications for diagnostics and treatment of gut-related diseases, opening new avenues in synthetic biology combined with digital health technology for personalized medicine.